129,589 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Acquired by Blair William & Co. IL

Blair William & Co. IL purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 129,589 shares of the medical instruments supplier’s stock, valued at approximately $3,228,000. Blair William & Co. IL owned about 0.06% of DENTSPLY SIRONA at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Generation Investment Management LLP lifted its stake in shares of DENTSPLY SIRONA by 43.4% during the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock worth $234,830,000 after buying an additional 1,998,012 shares during the last quarter. Wellington Management Group LLP raised its holdings in DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after acquiring an additional 1,419,503 shares during the period. SG Americas Securities LLC lifted its position in DENTSPLY SIRONA by 2,959.1% during the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after acquiring an additional 1,328,525 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after acquiring an additional 1,308,411 shares during the period. Finally, Cooke & Bieler LP grew its position in shares of DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analyst Ratings Changes

XRAY has been the subject of several research reports. Stifel Nicolaus dropped their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Needham & Company LLC restated a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Finally, Barrington Research restated an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a research report on Friday. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $33.22.

DENTSPLY SIRONA Trading Down 2.3 %

Shares of XRAY opened at $26.29 on Monday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. DENTSPLY SIRONA Inc. has a 52-week low of $23.58 and a 52-week high of $37.60. The firm has a market cap of $5.46 billion, a price-to-earnings ratio of -59.75, a PEG ratio of 1.25 and a beta of 1.00. The business’s fifty day moving average is $25.56 and its 200-day moving average is $27.82.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The business had revenue of $984.00 million during the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business’s revenue was down 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.51 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be given a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.43%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.